Part of Oral Answers to Questions — Prime Minister – in the House of Commons on 20th February 2019.

Alert me about debates like this

Photo of Theresa May Theresa May The Prime Minister, Leader of the Conservative Party

The hon. Lady has raised a particular case about Heidi, her constituent, and obviously I am sorry to hear that Heidi is in these circumstances. On the question of the drugs and treatments that are available, obviously we have a robust independent process through the National Institute for Health and Care Excellence reviews to look at new medicines that are possible, and this is the case with Spinraza. I am pleased that Biogen has, as I understand it, submitted a revised submission for the NICE appraisal committee to consider and a meeting has been arranged for 6 March when those recommendations will be considered.